Rockwell Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROCKWELL MEDICAL INC, and what generic alternatives to ROCKWELL MEDICAL INC drugs are available?
ROCKWELL MEDICAL INC has three approved drugs.
There are two US patents protecting ROCKWELL MEDICAL INC drugs.
There are nine patent family members on ROCKWELL MEDICAL INC drugs in eleven countries.
Summary for Rockwell Medical Inc
International Patents: | 9 |
US Patents: | 2 |
Tradenames: | 2 |
Ingredients: | 1 |
NDAs: | 3 |
Drugs and US Patents for Rockwell Medical Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-002 | Sep 4, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | POWDER;INTRAVENOUS | 208551-001 | Apr 25, 2016 | DISCN | Yes | No | 7,857,977 | ⤷ Sign Up | ⤷ Sign Up | ||||
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | DISCN | Yes | No | 7,816,404 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | POWDER;INTRAVENOUS | 208551-001 | Apr 25, 2016 | DISCN | Yes | No | 7,816,404 | ⤷ Sign Up | ⤷ Sign Up | ||||
Rockwell Medical Inc | TRIFERIC AVNU | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 212860-001 | Mar 27, 2020 | DISCN | Yes | No | 7,816,404 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rockwell Medical Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | 6,689,275 | ⤷ Sign Up |
Rockwell Medical Inc | TRIFERIC | ferric pyrophosphate citrate | SOLUTION;INTRAVENOUS | 206317-001 | Jan 23, 2015 | 6,779,468 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Rockwell Medical Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 5489196 | ⤷ Sign Up |
Cyprus | 1113903 | ⤷ Sign Up |
Portugal | 2016940 | ⤷ Sign Up |
Croatia | P20120416 | ⤷ Sign Up |
Canada | 2550493 | ⤷ Sign Up |
European Patent Office | 2016940 | ⤷ Sign Up |
Canada | 2638081 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.